Article

Identification of Potent Drugs and Antiviral Agents for the Treatment of the SARS-CoV-2 Infection

2020-05-20

Abstract excerpt

The recent outbreak of the SARS-CoV-2 infection has affected the lives and economy of more than 200 countries. The unavailability of vaccines and the virus-specific drugs has created an opportunity to repurpose existing drugs to examine their efficacy in controlling the virus activities. Here, the inhibition of the RdRp viral protein responsible for the replication of the virus in host cells is examined by evaluat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d845c34-d706-54ba-8900-c7091bf7621b
DOI: 10.26434/chemrxiv.12330599.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Potent Drugs and Antiviral Agents for the Treatment of the SARS-CoV-2 InfectionDOI 10.26434/chemrxiv.12330599.v1Read

In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and potentiality of the pre-existing drugsSemantic proximity Read

Nucleotide and nucleoside-based drugs: past, present, and futureSemantic proximity Read

Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2Semantic proximity Read

Genomics functional analysis and drug screening of SARS-CoV-2Semantic proximity Read

Prediction of binding of FDA approved drug Ledipasvir to SARS-CoV2 mutants: an in silico studySemantic proximity Read

Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approachSemantic proximity Read

Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRpSemantic proximity Read

Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting virusesSemantic proximity Read

SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspectiveSemantic proximity Read

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitroSemantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA‐dependent RNA polymerase of wild‐type and Delta subvariant AY.4 of SARS‐CoV‐2Semantic proximity Read